Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei

STARTSEITE
Current issue
Archives
Impressum
Datenschutz
 
 
arznei-telegramm®  10/2017

SPOT ON
Non-transparant information on research costs of the pharmaceutical industry … absurd calculations of no relevance
All-clear for postmenopaual hormones: how much truth is in it?

NEW ON THE MARKET
Group B meningococcal vaccine TRUMENBA

a-t READERS QUESTIONS AND COMMENTS
Cannabis on prescription?

THERAPY FROM A CRITICAL VIEWPOINT
EXSCELL trial with depot exenatide (BYDUREON)

IN BRIEF
Multiple vertebral fractures following treatment discontinuation of denosumab (PROLIA): EMA refuses to add a warning notice
ACE trial – no cardiovascular benefit of acarbose
Alternative cancer treatments
Atrial fibrillation and coronary stents: erratum

CURRENT ADR NETWORK REPORT
Psoriasis also with tocilizumab (ROACTEMRA)?

e a-t ON THE INTERNET
Oxygen therapy for myocardial infarction and stroke without benefit
Obeticholic acid (OCALIVA): fatal liver damages


© arznei-telegramm